Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | RAB9A | P51151 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.76 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | GAA | P10253 | 1/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.68 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.62 |
| ▸ | GSK3B | P49841 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.58 |
| ▸ | FEN1 | P39748 | 1/20 | 0.58 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.58 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fenbufen SCHEMBL11329267 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2FFAR1LMNACYP1A2RAB9A | |
| Fenbufen SCHEMBL11393779 | 0.98 | SMN1; SMN2 (0.96) | SMN1; SMN2FFAR1LMNACYP1A2RAB9A | |
| SCHEMBL10884944 | 0.94 | SMN1; SMN2 (0.88) | SMN1; SMN2FFAR1LMNACYP1A2RAB9A | |
| SCHEMBL8534233 | 0.91 | SMN1; SMN2 (0.84) | SMN1; SMN2FFAR1LMNACYP1A2RAB9A | |
| Fenbufen SCHEMBL8199650 | 0.89 | FFAR1 (0.80) | SMN1; SMN2FFAR1LMNACYP1A2RAB9A | |
| SCHEMBL3809685 | 0.88 | SMN1; SMN2 (0.79) | SMN1; SMN2FFAR1LMNACYP1A2RAB9A | |
| SCHEMBL354105 | 0.87 | NR4A2 (1.00) | SMN1; SMN2FFAR1LMNACYP1A2RAB9A | |
| SCHEMBL10353454 | 0.87 | NR4A2 (0.81) | SMN1; SMN2FFAR1LMNACYP1A2RAB9A | |
| SCHEMBL3383104 | 0.86 | HDAC8 (0.79) | SMN1; SMN2FFAR1LMNACYP1A2RAB9A | |
| SCHEMBL3381623 | 0.86 | HDAC8 (0.79) | SMN1; SMN2FFAR1LMNACYP1A2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 32180 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075406-A | Ensifen pharmaceutical composition, preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122016582-A | Particle size detection method of enkephalin | 江苏德迈药业有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| US-12569451-B2 | Bio-inspired tissue-adhesive hydrogel patch and uses thereof | Cellartgen Inc. (KR) | 2026-03-10 | — | — | US | claimed |
| US-20260027337-A1 | TRANSDERMAL DRUG DELIVERY DEVICES AND METHODS | MORNINGSIDE VENTURE INVESTMENTS LTD (MC) | 2026-01-29 | — | — | US | claimed |
| US-12515030-B2 | Transdermal drug delivery devices and methods | MORNINGSIDE VENTURE INVESTMENTS LIMITED (MC) | 2026-01-06 | — | — | US | claimed |
| US-20260000741-A1 | METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE | ACERAGEN INC (US) | 2026-01-01 | — | — | US | claimed |
| EP-3699174-B1 | COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME | ILAB (KR) | 2025-11-12 | — | — | EP | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| CN-120117987-A | Arylalkanoic acid phloroglucinol ester compound, preparation method and application thereof | 南华大学 | 2025-06-10 | — | — | CN | claimed |
| EP-0114886-A1 | IMPROVED ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING CAFFEINE. | SUNSHINE ABRAHAM (US) | 1984-08-08 | — | — | EP | claimed |
| WO-1984000490-A1 | IMPROVED ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING CAFFEINE AND METHODS OF USING SAME | SUNSHINE ABRAHAM | 1984-02-16 | — | — | WO | claimed |
| US-4390545-A | FENBUFEN AND B-OXO (OR) IMINO THIOPHENEPROPIONITRILES | AMERICAN CYANAMID COMPANY (US) | 1983-06-28 | — | — | US | claimed |
| EP-0012621-B1 | ANALGESIC COMPOSITION COMPRISING ACETAMINOPHEN AS A POTENTIATING AGENT | McNeilab, Inc. (US) | 1983-06-08 | — | — | EP | claimed |
| EP-0072462-A2 | Pharmaceutical preparations | Toko Yakuhin Industry Co., Ltd. (JP) | 1983-02-23 | — | — | EP | claimed |
| EP-0034270-A1 | Combinations of agents which give enhanced anti-inflammatory activity | AMERICAN CYANAMID COMPANY (US) | 1981-08-26 | — | — | EP | claimed |
| US-4233317-A | 3-(4-BIPHENYLYLCARBONYL)PROPIONIC ACID AND ACETAMINOPHEN | MCNEILAB, INC. (US) | 1980-11-11 | — | — | US | claimed |
| US-4219668-A | ANTITHROMBOTIC AND ANTIINFLAMMATORY AGENTS | AMERICAN CYANAMID COMPANY (US) | 1980-08-26 | — | — | US | claimed |
| EP-0012621-A1 | Analgesic composition comprising acetaminophen as a potentiating agent | McNeilab, Inc. (US) | 1980-06-25 | — | — | EP | claimed |
| US-3966960-A | 3-(4-Biphenylcarbonyl)propionic acid as an inhibitor of platelet aggregation | AMERICAN CYANAMID COMPANY (US) | 1976-06-29 | — | — | US | claimed |